{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T10:40:48Z","timestamp":1696588848518},"reference-count":37,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Care"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Nurses have an important role to play in the management of secondary hyperparathyroidism (SHPT). An online survey conducted by the European Dialysis and Transplant Nurses Association\/European Renal Care Association (EDTNA\/ERCA) in conjunction with Amgen (Europe) GmbH surveyed nephrology nurses\u2019 knowledge of secondary hyperparathyroidism, treatment targets, current treatments, patient adherence and nephrology nurse training education needs. The survey's aim was to establish common practices being used by nurses in the management of secondary hyperparathyroidism and to identify nephrology nurses\u2019 training and educational needs in order to improve patient care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Design: Descriptive study. Measurements: An online survey of multiple choice and closed questions. Participants: A sample of nephrology nurses from Spain, Italy, France and the Netherlands.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 111 nurses completed the questionnaire (98% response rate, 82% of which were fully completed). Collected data revealed that there were specific aspects of SHPT patient management where nurses lacked confidence, despite the majority of respondents having 15 years nephrology nursing experience. These aspects included explaining the disorder and therapies to patients, managing side effects of drugs and appreciating the significance of controlling biochemical targets. Over 40% of the respondents felt they did not have sufficient training to support patients who were non\u2010compliant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Nursing skills are integral to SHPT patient management as part of the multidisciplinary approach. The nurse's role is particularly important in patient assessment and monitoring, and in the provision of patient education and support, particularly with treatment adherence. Nephrology nurses who are better informed about SHPT and who receive training on practical patient care may improve the care of patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jorc.12120","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T04:01:33Z","timestamp":1429675293000},"page":"202-210","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AN OVERVIEW OF NURSES\u2019 MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM: HOW IS EUROPE DOING?"],"prefix":"10.1111","volume":"41","author":[{"given":"Ilaria","family":"de Barbieri","sequence":"first","affiliation":[{"name":"Nurse Paediatric Department Padua University Hospital Padua Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Baumann","sequence":"additional","affiliation":[{"name":"Amgen (Europe) GmbH Zug Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cruz","family":"Casal","sequence":"additional","affiliation":[{"name":"University Hospital 12 de Octubre Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey","family":"Gurevich","sequence":"additional","affiliation":[{"name":"Amgen (Europe) GmbH Zug Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitka","family":"Pancirova","sequence":"additional","affiliation":[{"name":"EDTNA\/ERCA CH\u20106003 Lucerne Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi\u2010Anna","family":"Poulia","sequence":"additional","affiliation":[{"name":"Clinical Dietician\u2010Nutritionist Laiko General Hospital of Athens Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aase","family":"Riemann","sequence":"additional","affiliation":[{"name":"Independent Renal Nurse Consultant Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000080087"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v31.pm9531176"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2010.11.006"},{"key":"e_1_2_10_5_1","first-page":"75","article-title":"Preventing and treating bone disorders in chronic kidney disease","volume":"8","author":"Coleman A.","year":"2011","journal-title":"British Journal of Primary Nursing Care"},{"key":"e_1_2_10_6_1","first-page":"963","article-title":"Central nervous system manifestations of hyperparathyroidism","volume":"65","author":"Cogan M.G.","year":"1978","journal-title":"American Journal of Kidney Diseases"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft514"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06040710"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01060308"},{"key":"e_1_2_10_10_1","unstructured":"DermNetNZ. (2014). Calciphylaxis. Available at:http:\/\/dermnetnz.org\/systemic\/calciphylaxis.html[accessed 24 April 2014]."},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00111-2"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1309\/AGLF-X21H-Y37W-50KL"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.82"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq219"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.186"},{"key":"e_1_2_10_16_1","first-page":"319","article-title":"Education for dialysis patients lowers long\u2010term phosphate levels and maintains health\u2010related quality of life","volume":"75","author":"Gardulf A.","year":"2011","journal-title":"Clinical Nephrology"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005183422003"},{"key":"e_1_2_10_18_1","first-page":"739","article-title":"Effect of secondary hyperparathyroidism on the anaemia of end\u2010stage renal failure: in vivo and in vitro studies","volume":"20","author":"Gr\u00fctzmacher P.","year":"1983","journal-title":"Proceedings of the European Dialysis and Transplant Association European Dialysis and Transplant Association"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107984"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000254388"},{"key":"e_1_2_10_21_1","first-page":"S1","article-title":"KDIGO Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2010mineral and bone disorder (CKD\u2010MBD)","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2010MBD Work Group","year":"2009","journal-title":"Kidney International Supplement"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-2-229"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2006.10.005"},{"issue":"3","key":"e_1_2_10_24_1","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-013-0637-2"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.4040"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.226"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08601209"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/104892"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01781-8"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-6686.2013.00343.x"},{"key":"e_1_2_10_32_1","unstructured":"Society forEndocrinology. (2013). Secondary hyperparathyroidism. Available at:http:\/\/www.yourhormones.info\/endocrine_conditions\/secondary_hyperparathyroidism.aspx[Accessed 25 April 2014]."},{"key":"e_1_2_10_33_1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1681\/ASN.V1101162","article-title":"Chronic parathyroid hormone excess in vivo increases resting levels of cytosolic calcium in brain synaptosomes: studies in the presence and absence of chronic renal failure","volume":"1","author":"Smogorzewski M.","year":"1991","journal-title":"Journal of the American Society of Nephrology"},{"key":"e_1_2_10_34_1","first-page":"H1998","article-title":"Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes","volume":"264","author":"Smogorzewski M.","year":"1993","journal-title":"American Journal of Physiology"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq602"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.02.340"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2702.2011.03967.x"},{"key":"e_1_2_10_38_1","first-page":"36","article-title":"Are CSN and NKF\u2010K\/ DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program","volume":"18","author":"Wazny L.D.","year":"2008","journal-title":"Canadian Association of Nephrology Nurses and Technologists Journal"}],"container-title":["Journal of Renal Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjorc.12120","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjorc.12120","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jorc.12120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T09:50:00Z","timestamp":1696499400000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jorc.12120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1111\/jorc.12120"],"URL":"https:\/\/doi.org\/10.1111\/jorc.12120","archive":["Portico"],"relation":{},"ISSN":["1755-6678","1755-6686"],"issn-type":[{"value":"1755-6678","type":"print"},{"value":"1755-6686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]},"assertion":[{"value":"2015-04-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}